So policy makers focus on «core inflation,» which ignores
changes in prices for fruit, vegetables, gasoline, fuel oil, natural gas, mortgage interest, intercity transportation, tobacco products and indirect taxes.
[2] CPIs, or consumer price indexes, measure
changes in price for a set of consumer goods and services.
The CPI measures
the change in prices for a basket of goods purchased by consumers.
Changes in the prices for productive resources affect the incomes of the owners of those productive resources and the combination of those resources used by firms.
The change in price for 2018 is similarly incremental; the QX80 is now $ 900 dearer for two - and four - wheel - drive models alike, weighing in at $ 65,745 and $ 68,845, respectively.
The CPI measures
the change in prices for a basket of goods purchased by consumers.
This can burden global operators, especially importers and exporters, that see abrupt
changes in the prices for importing and exporting when relevant currency values fluctuate.
For instance, if the NAV is RS 100and an exit load is 1 %, the redemption price would be Rs. 99 per unit Modified Duration Modified duration is the price sensitivity and the percentage
change in price for a unit change in yield.
Not surprisingly, many institutional and individual investors use the DJIA as an indicator of
changes in prices for the entire stock exchange.
Modified Duration is the name given to the price sensitivity and is the percentage
change in price for a unit change in yield.
Spread duration is commonly quantified as the percentage
change in price for the security (or portfolio) resulting from a 1.0 % (100 bps) change in spreads.
Duration is the percentage
change in price for a given percentage change in yield required by the market.
This is a market figure only and variations may not indicate
a change in the price for any particular property.
I, however, displayed the median sale prices for whole zip codes, not
the change in prices for individual homes.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected
in such forward - looking statements and that should be considered
in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential
for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases
in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of
changing customer preferences
for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest
in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions
in the industries and markets
in which we operate
in the U.S. and globally and any
changes therein, including fluctuations
in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain
in a timely fashion any required regulatory or other third party approvals
for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future
pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand
for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate
changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase
price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both
in the U.S. and abroad; 20) the effect of
changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and
changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such
changes; 21) any reduction
in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate
for our additional capital needs or
for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco
in a timely matter while avoiding any unexpected costs, charges, expenses, adverse
changes to business relationships and other business disruptions
for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations
in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Such factors include, among others, general business, economic, competitive, political and social uncertainties; the actual results of current and future exploration activities; the actual results of reclamation activities; conclusions of economic evaluations; meeting various expected cost estimates;
changes in project parameters and / or economic assessments as plans continue to be refined; future
prices of metals; possible variations of mineral grade or recovery rates; the risk that actual costs may exceed estimated costs; failure of plant, equipment or processes to operate as anticipated; accidents, labour disputes and other risks of the mining industry; political instability; delays
in obtaining governmental approvals or financing or
in the completion of development or construction activities, as well as those factors discussed
in the section entitled «Risk Factors»
in the Company's Annual Information Form
for the year ended December 31, 2017 dated March 15, 2018.
Seizing new opportunities will allow
for a more dynamic and sustainable trade and investment relationship with Asia that is less exposed to
changes in commodity
prices and demand.
As far back as 2002, while vice minister, Kuroda used an opinion column
in the Financial Times, co-written with his deputy at the finance ministry, to call
for «aggressive monetary policy» from the central bank, including an inflation target, aimed at «drastically
changing price expectations.»
After a two - year investigation by Canada's antitrust agency, Amazon Canada has agreed to
change its
pricing strategy
in Canada and pay a fine of Can $ 1.1 million (about US$ 840,000)
for displaying misleading
prices about savings.
Statistics: The Producer
Price Index, which measures the average
changes in selling
prices that domestic producers get
for the products they manufacture, will release its numbers
for June.
The software automatically
changes prices for the items on sale to guarantee that they stay competitive, but
in this instance, it generated a self - reinforcing loop
in which goods were automatically re-priced down to a penny.
«Now comes the hard part — communicating the need
for improvement
in a helpful way that motivates the employee to
change,»
Price says.
Low natural gas
prices, combined with
changes in the provincial tax regime, probably deserve as much credit as the worldwide economic downturn
for the carnage that has subsequently ensued, with at least 40 B.C. resort and condo developments
in creditor protection or receivership, according to Jurock.
Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions
in the industries and markets
in which United Technologies and Rockwell Collins operate
in the U.S. and globally and any
changes therein, including financial market conditions, fluctuations
in commodity
prices, interest rates and foreign currency exchange rates, levels of end market demand
in construction and
in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges
in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities
for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies
in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including
in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including
in connection with the proposed acquisition of Rockwell; (7) delays and disruption
in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational
changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of
changes in political conditions
in the U.S. and other countries
in which United Technologies and Rockwell Collins operate, including the effect of
changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates
in the near term and beyond; (16) the effect of
changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations
in the U.S. and other countries
in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result
in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including
in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market
price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted
in their operation of their businesses while the merger agreement is
in effect; (21) risks relating to the value of the United Technologies» shares to be issued
in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.
The company has responded with statements saying that it's not as dependent on drug
price increases as critics have claimed; it has also pointed out that while attention has focused on
changes in list
prices for drugs, those
prices don't reflect the actual cost
for insurers, governments and other group purchasers, which typically receive discounts that aren't publicly disclosed.
Tree — who said the policy
change restored a
price support
for growers by reintroducing a «federal risk premium» — told Business Insider that while consumers
in states were marijuana was legal were probably used to a high - quality and tested product, he suspected cracking down on legal marijuana production and sales would incentivize trafficking of lower - quality marijuana to states where the drug is still illegal.
Nothing about the drug has
changed in that time, and the fact that it's generic flies
in the face of the argument that lack of generic competition is the reason
for drastic
price hikes.
But a
change atop the U.S. central bank still adds to the uncertainty
in the market, and the pullback could test whether Powell's leadership will provide a «put» that supports stock
prices as had been the expectation
for investors under past Fed chairs.
Gold has regained its shine
in recent months, but that doesn't
change the dull outlook
for the precious metal over the longer - term, warns Goldman Sachs, which sees
prices falling to $ 1,000
in 12 months as the Federal Reserve normalizes monetary policy.
Zuora quotes The Economist with this bit of news: «80 % of companies are seeing a
change in how their customers want to access and pay
for good and services and 50 % of these same companies are
changing their
pricing models as a result.»
Copper
prices were responsible
for another major
change in 1997, when the penny's composition was switched to 98.4 % zinc with a copper plating.
First, I want to look at how the
changes not just
in oil
prices, but also
changes in diluent costs, discounts
for oil sands crude relative to light crude and,
in particular, the fall of the Canadian dollar have
changed the outlook
for new oil sands projects —
for those under construction, and
for those currently operating.
The Nordic region relies on hydroelectric power
for more than 50 percent of its power generation, and
change in precipitation is an important factor
in setting
prices.
Harper and his ministers are unlikely to cease their Keystone advocacy
in response to the veto — with oil
prices in a slump, the government can afford to wait
for a
change of president.
* Fed meeting on Wednesday
in focus
for rate hike clues (New throughout, updates
prices, market activity and comments to U.S. market open, new byline,
changes dateline, previous LONDON)
(Updates
prices, market activity and comments to U.S. market open, new byline,
changes dateline, previous LONDON) NEW YORK, May 3 (Reuters)- The U.S. dollar was little
changed in choppy trading on Thursday as investors took profits from a rally that sent the greenback to its highest levels of the year and awaited Fridays payrolls data
for April.
Important factors that could cause our actual results and financial condition to differ materially from those indicated
in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand
for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us
for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of
changes in pricing, coverage and reimbursement
for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee
for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described
in the Risk Factors and
in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 10 - Q.
With the Chinese market a major driver of coal demand
in Asia, any policy
changes in the country will affect
prices, contributing to the likelihood of continued
price volatility
in the seaborne coal market, wrote Wood Mackenzie's principal analyst
for mining and metals fundamentals research, Rory Simington
in a Nov. 16 report.
Despite the
change, BlackBerry did not follow up with a significant
change in strategy, and the stock
price continues to suffer as a result, said James Moorman, an analyst
for S&P Capital IQ.
So he
changed CQC's
price structure
in a way that clarified his reason
for the increase.
Last year, the figure was 333,000, of which 184,000 came from the E.U. Even if you accept, as most do, that immigration has expanded the tax base and kept the
price of both food and services down, the influx —
for which there is no end
in sight — is
changing the face of the country too fast
for the population to stomach, and the E.U.'s rules on free movement of labor are an easy target.
The bulk of the pieces are expected to fetch modest
prices — certainly compared to the $ 37 million that Warhol's Double Elvis (Ferus Type)
changed hands
for back
in May.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues
for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement
for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European countries that may increase the amount of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability of funding
for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations
in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations
in Gilead's earnings; market share and
price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering
prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications
for new product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a timely manner or at all,
for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta
in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to
changes in its stock
price, corporate or other market conditions; fluctuations
in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
«When you're talking about billions of dollars, a small
change is a significant difference
in the total
price for our customer,» he said.
They include a small - town conservation biologist and a couple of big - city ex-bankers who met after the easements law was
changed — at a moment
in the wake of the real estate crisis when investors began looking
for ways to salvage value from land whose
price had plummeted.
In addition, if you are a VC and you pay a bubble
price even at an early stage that can be hard to recover from (
for both you and the company) if the climate
changes radically.
In addition to offering temporary
price promotions or list -
price changes, companies can improve affordability by reducing the thresholds
for quantity discounts, extending credit to their customers, or having layaway plans.
These risks and uncertainties include competition and other economic conditions including fragmentation of the media landscape and competition from other media alternatives;
changes in advertising demand, circulation levels and audience shares; the Company's ability to develop and grow its online businesses; the Company's reliance on revenue from printing and distributing third - party publications;
changes in newsprint
prices; macroeconomic trends and conditions; the Company's ability to adapt to technological
changes; the Company's ability to realize benefits or synergies from acquisitions or divestitures or to operate its businesses effectively following acquisitions or divestitures; the Company's success
in implementing expense mitigation efforts; the Company's reliance on third - party vendors
for various services; adverse results from litigation, governmental investigations or tax - related proceedings or audits; the Company's ability to attract and retain employees; the Company's ability to satisfy pension and other postretirement employee benefit obligations;
changes in accounting standards; the effect of labor strikes, lockouts and labor negotiations; regulatory and judicial rulings; the Company's indebtedness and ability to comply with debt covenants applicable to its debt facilities; the Company's ability to satisfy future capital and liquidity requirements; the Company's ability to access the credit and capital markets at the times and
in the amounts needed and on acceptable terms; and other events beyond the Company's control that may result
in unexpected adverse operating results.
For more on the
price change in general — and how it affects you — please click here.
For example, the expected timing and likelihood of completion of the proposed merger, including the timing, receipt and terms and conditions of any required governmental and regulatory approvals of the proposed merger that could reduce anticipated benefits or cause the parties to abandon the transaction, the ability to successfully integrate the businesses, the occurrence of any event,
change or other circumstances that could give rise to the termination of the merger agreement, the possibility that Kraft shareholders may not approve the merger agreement, the risk that the parties may not be able to satisfy the conditions to the proposed transaction
in a timely manner or at all, risks related to disruption of management time from ongoing business operations due to the proposed transaction, the risk that any announcements relating to the proposed transaction could have adverse effects on the market
price of Kraft's common stock, and the risk that the proposed transaction and its announcement could have an adverse effect on the ability of Kraft and Heinz to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on their operating results and businesses generally, problems may arise
in successfully integrating the businesses of the companies, which may result
in the combined company not operating as effectively and efficiently as expected, the combined company may be unable to achieve cost - cutting synergies or it may take longer than expected to achieve those synergies, and other factors.